Michael Seldon

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry Iland, Ken Bradstock, Shane G. Supple et al. · Blood · 2012 · 340 citations · Full text

Medicine, Hematology, Oncology +15

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

Harry Iland, Marnie Collins, Ken Bradstock et al. · The Lancet Haematology · 2015 · 170 citations

Medicine, Hematology, Oncology +10

Fatigue during breast radiotherapy and its relationship to biological factors

Chris Wratten, Janice Kilmurray, Sharon Nash et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 160 citations

Medicine, Oncology, Radiation Oncology +14

Factor deficiencies in venom‐induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP‐10)

Geoffrey K. Isbister, Fiona E. Scorgie, Margaret A. O’Leary et al. · Journal of Thrombosis and Haemostasis · 2010 · 104 citations

Veterinary Medicine, Clinical Toxicology, Toxicology +15

Acetaminophen Causes an Increased International Normalized Ratio by Reducing Functional Factor VII

Ian M. Whyte, Nicholas A. Buckley, David Reith et al. · Therapeutic Drug Monitoring · 2000 · 93 citations

Medicine, Pharmacology, Toxicology +10